Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition

Montse Solé, María Esteban-Lopez, Biel Taltavull, Cristina Fábregas, Rut Fadó, Núria Casals, Jose Rodríguez-Álvarez, Alfredo J. Miñano-Molina, Mercedes Unzeta

Research output: Contribution to journalArticleResearch

3 Citations (Scopus)

Abstract

© 2019 Elsevier B.V. Dysfunctions of the vascular system directly contribute to the onset and progression of Alzheimer's disease (AD). The blood-brain barrier (BBB) shows signs of malfunction at early stages of the disease. When Abeta peptide (Aβ) is deposited on brain vessels, it induces vascular degeneration by producing reactive oxygen species and promoting inflammation. These molecular processes are also related to an excessive SSAO/VAP-1 (semicarbazide-sensitive amine oxidase) enzymatic activity, observed in plasma and in cerebrovascular tissue of AD patients. We studied the contribution of vascular SSAO/VAP-1 to the BBB dysfunction in AD using in vitro BBB models. Our results show that SSAO/VAP-1 expression is associated to endothelial activation by altering the release of pro-inflammatory and pro-angiogenic angioneurins, most highly IL-6, IL-8 and VEGF. It is also related to a BBB structure alteration, with a decrease in tight-junction proteins such as zona occludens or claudin-5. Moreover, the BBB function reveals increased permeability and leukocyte adhesion in cells expressing SSAO/VAP-1, as well as an enhancement of the vascular Aβ deposition induced by mechanisms both dependent and independent of the enzymatic activity of SSAO/VAP-1. These results reveal an interesting role of vascular SSAO/VAP-1 in BBB dysfunction related to AD progression, opening a new window in the search of alternative therapeutic targets for fighting AD.
Original languageEnglish
Pages (from-to)2189-2202
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1865
DOIs
Publication statusPublished - 1 Sep 2019

Keywords

  • Alzheimer's disease (AD)
  • Angioneurins
  • Blood-brain barrier (BBB)
  • Neurovascular unit (NVU)
  • Semicarbazide-sensitive amine oxidase (SSAO/VAP-1)

Fingerprint Dive into the research topics of 'Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition'. Together they form a unique fingerprint.

Cite this